Apollo Endosurgery
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-8.72-2.82-0.58-0.11-2.78-1.49-2.23-3.42-10.32-10.17-5.15-1.49
Price/Sales ratio
7.169.183.650.071.181.121.211.844.045.272.681.18
Price/Book Value ratio
5.742.950.550.111.522.3628.9111.464.1612.439.271.52
Price/Cash Flow ratio
-4.35-3.07-0.49-0.36-5.70-2.95-2.39-3.71-17.63-12.96-6.57-2.95
Price/Free Cash Flow ratio
-4.22-2.96-0.48-0.31-4.91-2.62-2.30-3.60-16.02-11.91-6.12-2.62
Price/Earnings Growth ratio
0.09-0.020.00-0.000.02-0.090.040.150.60-0.520.150.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%61.06%61.78%54.54%50.62%52.89%55.50%55.20%55.62%55.62%
Operating Profit Margin
-95.04%-350.46%-678.87%-32.00%-34.89%-65.88%-57.42%-37.56%-30.47%-36.20%-40.10%-65.88%
Pretax Profit Margin
-82.19%-325.85%-625.73%-62.86%-41.96%-74.92%-53.55%-53.43%-38.93%-51.07%-51.28%-51.28%
Net Profit Margin
-82.19%-325.85%-625.73%-63.46%-42.43%-75.24%-54.09%-53.77%-39.18%-51.83%-52.00%-52.00%
Effective Tax Rate
N/A-7.55%-8.49%-0.94%-1.12%-0.41%-1.01%-0.63%-0.63%-1.48%-1.41%-0.41%
Return on Assets
-41.89%-78.99%-86.20%-40.31%-25.02%-61.48%-36.78%-29.19%-18.76%-36.14%-53.23%-61.48%
Return On Equity
-65.85%-104.67%-95.04%-97.05%-54.67%-158.81%-1292.13%-334.92%-40.30%-122.22%-131.79%-131.79%
Return on Capital Employed
-62.54%-106.60%-103.11%-25.36%-26.95%-80.15%-133.63%-24.01%-16.40%-39.35%-64.00%-80.15%
Liquidity Ratios
Current Ratio
3.804.328.562.152.231.960.965.01N/AN/A2.342.23
Quick Ratio
3.724.328.561.551.671.560.794.137.091.881.821.67
Cash ratio
3.354.068.220.941.180.980.563.106.261.441.441.18
Days of Sales Outstanding
59.8652.241.5959.1366.5668.3266.4471.3358.3971.1948.4968.32
Days of Inventory outstanding
N/AN/AN/A175.78213.00131.06129.23189.92155.81193.43133.02131.06
Operating Cycle
N/AN/AN/A234.91279.57199.38195.67261.26214.21264.62144.97199.38
Days of Payables Outstanding
N/AN/AN/A74.35272.16201.79144.3467.7259.6978.6554.08201.79
Cash Conversion Cycle
N/AN/AN/A160.567.40-2.4051.32193.53154.52185.9727.207.40
Debt Ratios
Debt Ratio
0.36N/AN/A0.380.300.280.720.740.400.490.700.30
Debt Equity Ratio
N/AN/AN/A0.920.660.7325.408.570.871.662.380.66
Long-term Debt to Capitalization
N/AN/AN/A0.480.400.420.890.890.460.510.510.40
Total Debt to Capitalization
N/AN/AN/A0.480.400.420.960.890.460.620.620.40
Interest Coverage Ratio
N/AN/AN/A-1.14-4.97-7.95-7.18-3.00N/AN/A-6.37-7.95
Cash Flow to Debt Ratio
N/AN/AN/A-0.32-0.39-1.09-0.47-0.35-0.26-0.57-0.85-1.09
Company Equity Multiplier
1.571.321.102.402.182.5835.1311.472.143.383.382.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.64-2.98-7.41-0.19-0.20-0.37-0.50-0.49-0.22-0.40-0.40-0.37
Free Cash Flow / Operating Cash Flow Ratio
1.021.031.021.181.161.121.031.031.101.081.071.12
Cash Flow Coverage Ratio
N/AN/AN/A-0.32-0.39-1.09-0.47-0.35-0.26-0.57-0.85-1.09
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-0.72-15.87-24.62-1.54-2.33N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A